PDRN ã³ã¹ã¡ã®å ç¥ãšãèšããREJURAN ãã¡ãã¯<c-PDRN 0.5%>ãå ¥ã£ãŠããçŸå®¹æ¶²ã§ãã ãšã€ãžã³ã°ã±ã¢ãå¬ã®ä¹Ÿç¥å¯Ÿçã«è³Œå ¥ããŸããããŸã 䜿ãå§ãã§ããããã£ã¡ããã£ãšãããŸãã ããããç¶ç¶ããŠããããšæããŸãð
ãã£ãšèŠãããããã¢ã€ãã REJURANÃçŸå®¹æ¶²
ååç»å | ååæ å ± | åèäŸ¡æ Œ | è©äŸ¡ | ã©ã³ãã³ã°IN | ç¹åŸŽ | ååãªã³ã¯ |
---|---|---|---|---|---|---|
REJURAN ãã¥ã¢ã« ãšãã§ã¯ã ã¢ã³ãã« | 8,250å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬104äœ | ãšãã£ãšãããã¯ã¹ãã£ãŒã§ããã£ããèãèŠã£ãŠæœ€ããããªäœ¿çšæã§ãð€ | 詳现ãèŠã | |
REJURAN ã¿ãŒã³ãªãŒããŒã¢ã³ãã« | 2,728å |
| ãã®ä»ã¢ã€ãããŠã©ã³ãã³ã°ç¬¬182äœ | èã®è¡šé¢ãã€ãããšããŠããŠå€æ¹ã®ããã¿ãæ°ã«ãªãã«ãããªããŸããïŒ | 詳现ãèŠã | |
REJURAN ã¢ã€ã¹ãã£ãŒããªãŒãã¡ã³ãã¢ã³ãã« | 3,850å |
| ãã®ä»ã¢ã€ãããŠã©ã³ãã³ã°ç¬¬196äœ | ãã£ã¡ããšããã¯ãªã¢ãªãã¯ã¹ãã£ã èãªãã¿ãããã£ãïŒïŒïŒïŒãã£ã±ãããšæããããã£ããä¿æ¹¿ | 詳现ãèŠã |
çŸå®¹æ¶²ã©ã³ãã³ã°
ååç»å | ååæ å ± | åèäŸ¡æ Œ | è©äŸ¡ | ã©ã³ãã³ã°IN | ç¹åŸŽ | ååãªã³ã¯ |
---|---|---|---|---|---|---|
SHISEIDO ã¢ã«ãã£ãã¥ãŒã³â¢ ãã¯ã©ã€ãžã³ã° ã»ã©ã | 9,900å(ç·šééšèª¿ã¹) |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬21äœ | ã¹ã«ã¹ã«ã£ãšäŒžã³ãŠãèã«ãªãããšã»ãã®ããã€æãæããŸãã åŸèã¯ãããã | 詳现ãèŠã | |
DECORTà ãªããœãŒã ã¢ããã³ã¹ãããªãã¢ã»ã©ã | 12,650å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬15äœ | ããããªã£ãããŸã£ãèãæãããã»ãããŠããããããªã€ã¡ãŒãžã§ããïŒ | 詳现ãèŠã | |
ã© ããã·ã¥ ã㌠ãšãã¡ã¯ã© ããŒã«ã±ã¢ ã»ã©ã | 5,280å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬53äœ | ããããšãã¿ã®ãããã¯ã¹ãã£ãŒã§ã䌞ã³è銎æã¿å ±ã«âã¹ãšã€ããªããã©ãã£ãšãä¿æ¹¿ããŠãããŸãïŒ | 詳现ãèŠã | |
REJURAN ãã¥ã¢ã« ãšãã§ã¯ã ã¢ã³ãã« | 8,250å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬104äœ | ãšãã£ãšãããã¯ã¹ãã£ãŒã§ããã£ããèãèŠã£ãŠæœ€ããããªäœ¿çšæã§ãð€ | 詳现ãèŠã | |
Torriden ãã€ãã€ã³ ã»ã©ã | 2,420å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬87äœ | èã«ã®ãããšããã«ã¹ããšéŠŽæã¿ãŸãã銎æããšãã¿ã€ãããããµã©ãµã©ã«ãªãïŒ | 詳现ãèŠã | |
Anua ã¢ãŒã©ã€ã³é ž15 ã€ã³ãã³ã¹ã«ãŒãã³ã°ã»ã©ã |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬102äœ | 軜ãããªãã¯ã¹ãã£ãŒã§çŽ æ©ãèã«éŠŽæã¿ã最ããããªäœ¿ãå¿å°ã§ãâš | 詳现ãèŠã | ||
numbuzin 5çª çœçã°ã«ã¿ããªã³ïŒ£çŸå®¹æ¶² | 2,420å |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬19äœ | ãšãã¿ã®ãããã¯ã¹ãã£ãŒãªã®ã«ããããããªãðð» | 詳现ãèŠã | |
Anua ããŒã¯ã¹ãããã»ã©ã |
| ã¹ãã³ã±ã¢ãããã©ã³ãã³ã°ç¬¬43äœ | ä¿æ¹¿æåããã£ã·ããšé åãããŠããŠã ããäžæ¬ã§ããèããã£ãšããšããŸãâš | 詳现ãèŠã | ||
ã¢ãŒã¬ã¹ ããŒã¹ã ãã³ã㌠X | 7,150å(ç·šééšèª¿ã¹/ãªãŒãã³äŸ¡æ Œ) |
| ãã©ã€ã¢ã«ãããã©ã³ãã³ã°ç¬¬44äœ | ãã¿ãã¿ãã«ããã èãªãã¿ãããã®ã§äœ¿ããããïŒãèã«ãã€ãã§ãã®ãå¬ããð | 詳现ãèŠã | |
GUERLAIN ã¢ãã€ãŠ ãã€ã€ã« ãŠã©ãŒã¿ãªãŒ ãªã€ã« ã»ãã | 19,800å |
| ãã©ã€ã¢ã«ãããã©ã³ãã³ã°ç¬¬91äœ | 詳现ãèŠã |
ããð°ð€ãã©ããðð€ããã®äººæ°ã¯ãã³ã
è²æã¯Twitterã®ãã£ã³ããŒã³ðã§ ã¹ããŒãæ§ããããã ããŸããïŒ åœéžããæã¯ã»ããšä¿¡ããããªãããã å¬ããããŠæåäžå¯©ã«ãªã£ãâŠððç¬ ããããªçŽ æµãªãã®ããããã«äŒŒåãã®âŠïŒã ã£ãŠããããããŠæ¬åœã«å¬ããã£ãæãåºð€ å¹»å èã¯ããå»ç€ã§ãã¶ãäœ¿çšæéãâŠâŠ ã ãã©ãã£ãšå€§åã«æã§ãŠããŸãð¥¹ð
ãã£ãšèŠã331
6
- 2024.06.05
CLIOãã ã¢ã€ ãã¬ãã102 CHERISH SPRING CLIOã®æ¹ããŽã£ããð«¶ ããã¢ã€ãã¬ããïŒã€æã£ãŠããã© ãããïŒçªã®ãæ°ã«å ¥ãðžâš ãã€ãžãŒã¯ã¯çœã¿åŒ·ãããªã ãªããªãé£ãããŠãŸã ç ç©¶äžâŠð¹ ã§ãæ¬åœã«å¯æããŠå¯æã㊠çºããŠãã ãã§å¹žããðžç¬
ãã£ãšèŠã276
8
- 2024.06.15
åããªããŒã«ãã³ã¯ð©· ããªãæ¿ãéã¿ãã³ã¯ã«èŠãããã© çœã¿ããã£ãŠæ¬åœã«äœ¿ããããïŒ ãéããçœãããã»ã©ãããã¬ã³ã ãããŠããã ã£ãŠðâš çŸå°å¥³ããŒã¯ã£ãŠæããããã㩠倧人ã§ã䜿ããæ·¡ãè¡è²ã«ã©ãŒã§ã𥰠ãããUNMIXâš ãã®æã€ã³ãã«ãšã³ã¶ã®é«ç±ã§ããããŠãŸãã⊠ã§ãããŒã²ã³ããªã¢ãçŸããããŠâŠð¥¹
ãã£ãšèŠã240
5
- 2024.06.05
ãæé äŸ¡æ Œã ãã©è¯ãããð»â𠿬¡ã¯ãªããïŒãªãã¢ãè²·ãããð¥¹ð ã·ã£ã³ããŒã¯æ³¡ç«ã¡è¯ããŠããã¿ã¯å šç¶æããªãð(ç§ã¯é«ªã®æ¯ã€ãã€ã) ã³ã³ãã£ã·ã§ããŒããªãã¿è¯ããšãŠã䜿ããããã§ãâš HIMAWARIð»ããªãè¯ããšæã£ãã®ã§ 次ã¯è²·ããšãã«ã¯ãªããïŒãªãã¢ãéžãã§è©ŠããŠã¿ãããšæããŸããð¥°
ãã£ãšèŠã160
3
- 2024.09.12
ããããã¿ãšã°ãã«ããã£ãŠèããŠ éæ»è²·ã£ããã ãã©ðãããããŒã¹ã« ãããšãªã¬ã³ãžãããæã䜿ããæ§ã«ãªããŸãããŒãŒð¥³ ãã€ïŒã©ã¡âŠã£ãŠæãã§è²ã¯ã»ãšãã© ã€ããªãã®ã§ã¢ã€ã·ã£ããŠããŒã¹ãšããŠã»ãŒæ¯æ¥äœ¿ã£ãŠãããŸããå¿ éåïŒ ã¯ãªãŒã ã·ã£ããŠãªã®ã«ãµã©ããšããŠãð«° ãã£ãããããŒãã³ã¯ã®ããŒã¹ã§ 现ããã©ã¡ããããŒã綺éºâš
ãã£ãšèŠã154
15
- 2024.06.11
ãã³ãããŒã«ïŒçŸå®¹éïŒããªèã«ãªããâšâšãšããæå³ã蟌ããããŠããããã§ãã𥰠ã¢ã©ãã©ãŒã®ç§ã«ããŽã£ããð æ°Žåæãã£ã·ãã®ãã¯ã¹ãã£ãŒïŒ ä»ãŸã§äœ¿ã£ãéçŸå®¹æ¶²ã®äžã§ïŒçªã¿ãã¿ãããããïŒâš ãèã®èª¿åãäžããæ°ãããŸãâ€Žïž äœ¿ãç¶ããã®ã楜ãã¿ð
ãã£ãšèŠã152
2
- 2024.10.28
åå詳现æ å ±REJURAN ãã¥ã¢ã« ãšãã§ã¯ã ã¢ã³ãã«
- ãã©ã³ãå
- REJURAN(ãªãžã¥ã©ã³)
- ã©ã³ãã³ã°IN
- å šäœã©ã³ãã³ã°å¹Žä»£å¥ã©ã³ãã³ã°è質å¥ã©ã³ãã³ã°
- 容éã»åèäŸ¡æ Œ
- 30ml: 8,250å
- åå説æ
- ãªãžã¥ã©ã³ã®ãªãªãžãã«PDRNãå ¥ã£ãŠããããªãã€çŸå®¹æ¶²ã c-PDRNâ»1 ããã€ã¢ã·ã³ã¢ããâ»2ããã¢ã«ãã³é žïŒ®ïœâ»2 ãã«ã³ãŸãŠæ ¹ãšãã¹â»3ãé åã è§è³ªå±€ãŸã§æœ€ããäžããèãªãºã ãæŽããâ»4ããšã§åŒŸåã®ããèæ¬æ¥ã®çŸãããžã ãªãžã¥ã©ã³æé«æè¡ã¹ããŒãšã€ãžã³ã°â»5äžèœçŸå®¹æ¶²ã â»1ãå æ°Žå解 : æŽèæå â»2ãé åç®çïŒä¿æ¹¿ â»3ãé åç®ç: æŽèæå â»4ãèããããã£ãŠããããããªç¶æ ã®ããš â»5ã幎霢ã«åãããã±ã¢ã®ããš
- ã¡ãŒã«ãŒå
- Pharma Research
- ã«ããŽãª
- ã¹ãã³ã±ã¢ã»åºç€åç²§å > çŸå®¹æ¶²
ã³ã¡ã³ã